News

A new Cleveland Clinic study has programmed EHRs to limit the rate of chest X-rays among patients. How has it helped both their stay and treatment progression rates?

Investigators have found that mice with ALS given the novel treatment showed significant improvements in their cognitive and motor performance.

A new cohort from the Cleveland Clinic shows that the index could allow ICU clinicians to know whether a patient needs prone positioning or ECMO.

The known medium of communication between the immune system and central nervous system, metabolites could believably play a role in the multiple sclerosis disease course.

William Lennarz, MD, shares about the positive aspects of providing pediatric emergency care in New Orleans, as well as the challenge of preparing for the next big hurricane.

Both sex- and age-specific therapies could come to clinical asthma field in upcoming years.

Ketamine looks promising as a potential therapy for treatment-resistant depression. The problem is that more research is needed to understand it.

William Lennarz, MD, describes the efforts among those in the specialty to reduce pain and anxiety during children's visits to the emergency room.

The t:Slim X2 insulin pump is both compatible with outside therapy systems, and capable of delivering insulin on its own.

New research shows women who are pregnant face a higher risk of ending up in the hospital, regardless of pregnancy stage.

A novel method to inactivate HCV in donor lungs could allow additional transplants without post-transplant antiviral treatment.

Pigment epithelial detachment is less responsive to anti-VEGF treatment, compared to subretinal fluid or intraretinal cysts in nAMD, investigators observed.

The CAROLINA cardiovascular safety study found that linagliptin was non-inferior to glimepiride in time to a composite cardiovascular endpoint.

A study of medical school applicants through their education showed those more expected to become a doctor by their parents are more likely to feel the strains of becoming one.

Successful HCV treatment with direct-acting antivirals provides long-term efficacy in resolving HCV-associated cryoglobulinemia vasculitis.

Hepatitis B virus may also accelerate the progression of the optical disease, according to investigators.

The FDA has approved triclabendazole (Egaten) for the treatment of fascioliasis, a neglected tropical disease in patients 6 years of age and older.

The EPIT skin patch is still seeking indication as the first peanut allergy desensitization therapy to reach the market.

MPN— myeloproliferative neoplasm—involves the production of too many red blood cells, white blood cells, or platelets in the body.

A 300,000-plus patient cohort analysis showed patients with atherosclerotic cardiovascular disease are at a significantly greater risk of death if they don't adhere to statin prescriptions.

A new CDC study found the flu vaccine was 38% effective last year, but it also stopped more than 100,000 hospitalizations.

Sustained virologic response was achieved regardless of the hepatitis C genotype.

Harvard University investigators found that both diacetyl and 2,3-pentanedione initiated changes in gene expressions that reduced the number of ciliated cells, and impacted how well they functioned.

If approved, Spravato would become the first novel mechanism of action in 30 years to treat major depressive disorder.

The US Preventive Services Task Force has recommended that clinicians refer pregnant and postpartum persons who are at risk of depression for counseling services.

Providers and patients now have the option to choose a first dose of daratumumab in 1 or 2 infusions.

Results suggest that pediatric patients with epilepsy should have genomic test results reinterpreted at least every 2 years and before further genetic testing.

Researchers determined that no relationship existed between haptoglobin polymorphism and frequent exacerbator status, though a negative one existed between exacerbator status and current smoking habits.